Literature DB >> 24094320

Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?

Glyn N Stacey1, Jeremy M Crook, Derek Hei, Tenneille Ludwig.   

Abstract

The generation of human embryonic stem cell banking networks has ensured that well-characterized and quality controlled stem cell lines are broadly accessible to researchers worldwide. Here, we provide recommendations for engaging these established networks in efforts to build similar resources for the distribution and collection of induced pluripotent stem cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 24094320     DOI： 10.1016/j.stem.2013.09.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  26 in total

1.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

Review 2.  New cell sources for T cell engineering and adoptive immunotherapy.

Authors:  Maria Themeli; Isabelle Rivière; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

3.  The microenvironment of embryoid bodies modulated the commitment to neural lineage postcryopreservation.

Authors:  Sébastien Sart; Yuanwei Yan; Yan Li
Journal:  Tissue Eng Part C Methods       Date:  2014-10-09       Impact factor: 3.056

Review 4.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Authors:  Kevin G Chen; Barbara S Mallon; Ronald D G McKay; Pamela G Robey
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

Review 5.  In vitro cardiac tissue models: Current status and future prospects.

Authors:  Anurag Mathur; Zhen Ma; Peter Loskill; Shaheen Jeeawoody; Kevin E Healy
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

6.  Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies.

Authors:  Mehdi Dashtban; Krishna Morgan Panchalingam; Mehdi Shafa; Behnam Ahmadian Baghbaderani
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

Authors:  Alain van Mil; Geerthe Margriet Balk; Klaus Neef; Jan Willem Buikema; Folkert W Asselbergs; Sean M Wu; Pieter A Doevendans; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2018-12-01       Impact factor: 10.787

Review 8.  Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.

Authors:  Anna French; Christopher Bravery; James Smith; Amit Chandra; Peter Archibald; Joseph D Gold; Natalie Artzi; Hae-Won Kim; Richard W Barker; Alexander Meissner; Joseph C Wu; Jonathan C Knowles; David Williams; Guillermo García-Cardeña; Doug Sipp; Steve Oh; Jeanne F Loring; Mahendra S Rao; Brock Reeve; Ivan Wall; Andrew J Carr; Kim Bure; Glyn Stacey; Jeffrey M Karp; Evan Y Snyder; David A Brindley
Journal:  Stem Cells Transl Med       Date:  2015-02-03       Impact factor: 6.940

9.  In vitro Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs).

Authors:  Agnieszka D'Antonio-Chronowska; Matteo D'Antonio; Kelly A Frazer
Journal:  Bio Protoc       Date:  2020-09-20

10.  Identifiability and privacy in pluripotent stem cell research.

Authors:  Rosario Isasi; Peter W Andrews; Jay M Baltz; Annelien L Bredenoord; Paul Burton; Ing-Ming Chiu; Sara Chandros Hull; Ji-Won Jung; Andreas Kurtz; Geoffrey Lomax; Tenneille Ludwig; Michael McDonald; Clive Morris; Huck Hui Ng; Heather Rooke; Alka Sharma; Glyn N Stacey; Clare Williams; Fanyi Zeng; Bartha Maria Knoppers
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.